These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35112216)

  • 1. 3D pseudo-continuous arterial spin labeling-MRI (3D PCASL-MRI) in the differential diagnosis between glioblastomas and primary central nervous system lymphomas.
    Batalov AI; Afandiev RM; Zakharova NE; Pogosbekyan EL; Shulgina AA; Kobyakov GL; Potapov AA; Pronin IN
    Neuroradiology; 2022 Aug; 64(8):1539-1545. PubMed ID: 35112216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of 3D-pCASL MRI in the Differential Diagnosis of Glioblastoma and Brain Metastases.
    Solozhentseva K; Batalov A; Zakharova N; Goryaynov S; Pogosbekyan E; Pronin I
    Front Oncol; 2022; 12():874924. PubMed ID: 35558515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical primary central nervous system lymphoma and glioblastoma: multiparametric differentiation based on non-enhancing volume, apparent diffusion coefficient, and arterial spin labeling.
    Yu X; Hong W; Ye M; Lai M; Shi C; Li L; Ye K; Xu J; Ai R; Shan C; Cai L; Luo L
    Eur Radiol; 2023 Aug; 33(8):5357-5367. PubMed ID: 37171492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Primary Central Nervous System Lymphoma From Glioblastoma: Quantitative Analysis Using Arterial Spin Labeling and Diffusion Tensor Imaging.
    Abdel Razek AAK; El-Serougy L; Abdelsalam M; Gaballa G; Talaat M
    World Neurosurg; 2019 Mar; 123():e303-e309. PubMed ID: 30502475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of Skull Base Lesions Using Pseudo-Continuous Arterial Spin Labeling.
    Geerts B; Leclercq D; Tezenas du Montcel S; Law-Ye B; Gerber S; Bernardeschi D; Galanaud D; Dormont D; Pyatigorskaya N
    Clin Neuroradiol; 2019 Mar; 29(1):75-86. PubMed ID: 28894884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of arterial spin labelling MRI for discriminating atypical high-grade glioma from primary central nervous system lymphoma.
    Di N; Cheng W; Chen H; Zhai F; Liu Y; Mu X; Chu Z; Lu N; Liu X; Wang B
    Clin Radiol; 2019 Feb; 74(2):165.e1-165.e9. PubMed ID: 30415766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability measurement using dynamic susceptibility contrast magnetic resonance imaging enhances differential diagnosis of primary central nervous system lymphoma from glioblastoma.
    Lee JY; Bjørnerud A; Park JE; Lee BE; Kim JH; Kim HS
    Eur Radiol; 2019 Oct; 29(10):5539-5548. PubMed ID: 30877463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of brain perfusion in newborns: pulsed arterial spin labeling (PASL) versus pseudo-continuous arterial spin labeling (pCASL).
    Boudes E; Gilbert G; Leppert IR; Tan X; Pike GB; Saint-Martin C; Wintermark P
    Neuroimage Clin; 2014; 6():126-33. PubMed ID: 25379424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
    Li J; Xue M; Yan S; Guan C; Xie R; Chen B
    BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-invasive assessment of intratumoral vascularity using arterial spin labeling: A comparison to susceptibility-weighted imaging for the differentiation of primary cerebral lymphoma and glioblastoma.
    Furtner J; Schöpf V; Preusser M; Asenbaum U; Woitek R; Wöhrer A; Hainfellner JA; Wolfsberger S; Prayer D
    Eur J Radiol; 2014 May; 83(5):806-10. PubMed ID: 24613549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
    Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
    Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of three-dimensional pseudo-continuous arterial spin labeling perfusion imaging with gradient-echo and spin-echo dynamic susceptibility contrast MRI.
    Wong AM; Yan FX; Liu HL
    J Magn Reson Imaging; 2014 Feb; 39(2):427-33. PubMed ID: 23677620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
    Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
    Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of progressive disease from pseudoprogression using 3D PCASL and DSC perfusion MRI in patients with glioblastoma.
    Manning P; Daghighi S; Rajaratnam MK; Parthiban S; Bahrami N; Dale AM; Bolar D; Piccioni DE; McDonald CR; Farid N
    J Neurooncol; 2020 May; 147(3):681-690. PubMed ID: 32239431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perfusion measurement in brain gliomas using velocity-selective arterial spin labeling: comparison with pseudo-continuous arterial spin labeling and dynamic susceptibility contrast MRI.
    Qu Y; Kong D; Wen H; Ou X; Rui Q; Wang X; Lin DD; Qin Q; Wen Z
    Eur Radiol; 2022 May; 32(5):2976-2987. PubMed ID: 35066634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arterial Spin Labeling Perfusion in Determining the IDH1 Status and Ki-67 Index in Brain Gliomas.
    Batalov AI; Zakharova NE; Chekhonin IV; Pogosbekyan EL; Sudarikova AV; Goryainov SA; Shulgina AA; Belyaev AY; Usachev DY; Pronin IN
    Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor blood flow from arterial spin labeling perfusion MRI: a key parameter in distinguishing high-grade gliomas from primary cerebral lymphomas, and in predicting genetic biomarkers in high-grade gliomas.
    Yoo RE; Choi SH; Cho HR; Kim TM; Lee SH; Park CK; Park SH; Kim IH; Yun TJ; Kim JH; Sohn CH; Han MH; Chang KH
    J Magn Reson Imaging; 2013 Oct; 38(4):852-60. PubMed ID: 23390061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differentiation between primary CNS lymphoma and glioblastoma: qualitative and quantitative analysis using arterial spin labeling MR imaging.
    You SH; Yun TJ; Choi HJ; Yoo RE; Kang KM; Choi SH; Kim JH; Sohn CH
    Eur Radiol; 2018 Sep; 28(9):3801-3810. PubMed ID: 29619520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of cerebral blood flow using multi-phase pseudo continuous arterial spin labeling at 3-tesla.
    Sugimori H; Fujima N; Suzuki Y; Hamaguchi H; Sakata M; Kudo K
    Magn Reson Imaging; 2015 Dec; 33(10):1338-1344. PubMed ID: 26260545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiating primary CNS lymphoma from glioblastoma multiforme: assessment using arterial spin labeling, diffusion-weighted imaging, and ¹⁸F-fluorodeoxyglucose positron emission tomography.
    Yamashita K; Yoshiura T; Hiwatashi A; Togao O; Yoshimoto K; Suzuki SO; Abe K; Kikuchi K; Maruoka Y; Mizoguchi M; Iwaki T; Honda H
    Neuroradiology; 2013 Feb; 55(2):135-43. PubMed ID: 22961074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.